Profile
Claes Tomas Post is currently a Director at Oblique Therapeutics AB and STOAF III Venture Partners AB. He is also a Director at Apotekarsocieteten since 2014 and a General Partner at Stockholms Affärsänglar Management AB since 2017.
In the past, he served as the Chief Executive Officer at Melacure Therapeutics AB from 2003 to 2005, and as the Chief Executive Officer at Karolinska Institutet Innovations AB from 2008 to 2011.
He was also a Venture Partner at HealthCap AB and Nordic Biotech Advisors ApS.
Dr. Post holds a graduate degree from the University of Uppsala and a doctorate degree from the University of Linköping.
Claes Tomas Post active positions
| Companies | Position | Start |
|---|---|---|
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Director/Board Member | - |
STOAF III Venture Partners AB | Director/Board Member | - |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1988-08-31 |
Stockholms Affärsänglar Management AB
Stockholms Affärsänglar Management AB Investment ManagersFinance STOAF invests in companies located in the Nordic region primarily in Sweden. The firm targets companies operating in the fields of life sciences, advanced industrial technologies, advanced ICT and sustainable energy technologies. It provides financing for early stage capital requirements and offers co-investment rights to limited partners. | Private Equity Investor | 2016-12-31 |
Apotekarsocieteten | Director/Board Member | 2013-12-31 |
Former positions of Claes Tomas Post
| Companies | Position | End |
|---|---|---|
| XINTELA AB | Director/Board Member | 2020-02-29 |
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Director/Board Member | 2018-02-28 |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2017-02-28 |
Almi Invest AB
Almi Invest AB Investment ManagersFinance Almi invests in companies located in Sweden. The firm targets companies operating in the fields of tech & deeptech, industry, life science and sustainability sectors. It provides financing for pre-seed, seed and growth transactions with an investment size of SEK 1 - 10 million. The firm takes seat on board of directors and makes co-investments. | Chief Investment Officer | 2015-09-29 |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Claes Tomas Post
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 30 |
|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Melacure Therapeutics AB
Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Health Technology |
Astra LLC
Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems | Distribution Services |
Astra Draco AB | |
AroCell AB
AroCell AB Medical SpecialtiesHealth Technology Provides cancer therapy | Health Technology |
KDev Exploratory AB
KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions | Commercial Services |
Denator AB
Denator AB Medical SpecialtiesHealth Technology Provides instruments and consumables that stabilize biological samples | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Pharmacia Upjohn | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Operates, develops, and finances projects in-house and utilizes research to improve human health | Finance |
Pharmacia Italia Spa | |
Almi Invest AB
Almi Invest AB Investment ManagersFinance Almi invests in companies located in Sweden. The firm targets companies operating in the fields of tech & deeptech, industry, life science and sustainability sectors. It provides financing for pre-seed, seed and growth transactions with an investment size of SEK 1 - 10 million. The firm takes seat on board of directors and makes co-investments. | Finance |
AddBIO AB
AddBIO AB BiotechnologyHealth Technology Provides bone implant technology solutions | Health Technology |
Sprint Bioscience AB
Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Stockholms Affärsänglar Management AB
Stockholms Affärsänglar Management AB Investment ManagersFinance STOAF invests in companies located in the Nordic region primarily in Sweden. The firm targets companies operating in the fields of life sciences, advanced industrial technologies, advanced ICT and sustainable energy technologies. It provides financing for early stage capital requirements and offers co-investment rights to limited partners. | Finance |
Xintela AB
Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases | Health Technology |
Gradientech AB
Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Health Technology |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods | Health Technology |
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Provides scientific and technical research and development services | Health Technology |
Dicot Pharma AB
Dicot Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs to treat erectile failure | Health Technology |
Astra Pain Control AB | |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
Ct Post AB
Ct Post AB Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
STOAF III Venture Partners AB | |
Apotekarsocieteten |
- Stock Market
- Insiders
- Claes Tomas Post
















